bapineuzumab en · NOUN
Etymology
From [Term?] + neu(ral) + -zumab (“humanized monoclonal antibody”).
Meanings
-
(uncountable) A humanized monoclonal antibody that acts on the nervous system and has potential therapeutic value for the treatment of Alzheimer's disease and possibly glaucoma.
In 2012, Pfizer and Johnson & Johnson halted development of the antibody drug bapineuzumab, after it failed in late-stage trials to treat patients with mild to moderate Alzheimer’s.
2018 January 18, Jürgen Götz, “Why it’s so hard to treat dementia”, in CNN: